| ENOVIS CORP. |
| USA |
| Gesundheit |
| US1940145022 / A3DHHV |
| C520 (Frankfurt) / ENOV (NYSE) |
| FRA:C520, ETR:C520, C520:GR, NYSE:ENOV |
| - |
| https://enovis.com/ |
|
Enovis Corporation is a diversified healthcare equipment company focused on developing and supplying a broad range of innovative medical technology solutions. The primary function of the company is to enhance patient care and improve treatment outcom..
>Volltext.. |
| 1132.34 Mio. EUR |
| 2326.26 Mio. EUR |
| 1991.95 Mio. EUR |
| 304.66 Mio. EUR |
| -992.83 Mio. EUR |
| -17.36 EUR |
| 1233.2 Mio. EUR |
| 28.96 Mio. EUR |
| 212.31 Mio. EUR |
| 0.05 |
| -0.78% |
| -31.36% |
| - |
| - |
| - |
| ENOVIS |
| 06.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|